markets a medical device that monitors breathing patterns and delivers nerve stimulation to maintain open airways. The device consists of a remote control and 3 implantable components including a sensing lead, stimulator and stimulation lead.
1/3 of those with CPAP machines are noncompliant. 70% of those are eligible for the INSP solution.
5/17 Company is richly valued at 14x sales.
Public company RMD is competition and potential acquirer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.